Andrew B. Sharabi

ORCID: 0000-0003-2075-1197

Also affiliated with University of California San Diego

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers”.

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0161

N/A

0.700DataRank · unranked

105 citations

Aaron M. Goodman, Ryosuke Okamura, Donald A. Barkauskas, Theresa J. Whitchurch, Suzanna Lee +9 more

Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0697

N/A

0DataRank · unranked

84 citations

Whitney A. Sumner, Sayuri Miyauchi, Ezra E.W. Cohen, Joseph A. Califano, Andrew B. Sharabi +1 more

Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.07.471658

N/A

0DataRank · unranked

3 citations

Robert Saddawi‐Konefka, Victoria H. Wu, Miguel Angel Lopez‐Ramirez, Zhiyong Wang, Fernando Soto +11 more

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Nature Communications(2022)10.1038/s41467-022-31941-w

N/A

0DataRank · unranked

176 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen +17 more

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108114

N/A

0DataRank · unranked

136 citations

Andrew B. Sharabi, Shweta Joshi

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Nature Communications(2022)10.1038/s41467-022-31601-z

N/A

0DataRank · unranked

66 citations

Michael M. Allevato, Maria F. Camargo, Jacqueline Lesperance, Maryam A. Quraishi, Joseph Aguilera +12 more

Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0234

N/A

0DataRank · unranked

46 citations

Robert Saddawi‐Konefka, Victoria H. Wu, Miguel Angel Lopez‐Ramirez, Zhiyong Wang, Fernando Soto +11 more

Germline genetic biomarkers to stratify patients for personalized radiation treatment

Journal of Translational Medicine(2022)10.1186/s12967-022-03561-x

N/A

0DataRank · unranked

14 citations

Austin Hopper, Lena Krockenberger, Timothy J. Sears, Leisa Sutton, Xenia Ray +6 more

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.01.478744

N/A

0DataRank · unranked

9 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Nana-Ama A.S. Anang +16 more

Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway

Cell Reports(2023)10.1016/j.celrep.2023.112508

N/A

0DataRank · unranked

54 citations

Sangwoo S. Kim, Riley N. Jones, Lin Zhang, Kripa Guram, Sonia Sharma +5 more

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1148317

N/A

0DataRank · unranked

19 citations

In Hwan Park, Timothy V. Pham, Riley N. Jones, Elisabette Tapia, Kevin X. Liu +5 more

Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.09.035

N/A

0DataRank · unranked

5 citations

Tyler J. Nelson, Hannah C. Liu, Prangrawee Sangchan, Bhargava Chitti, Caroline A. Thompson +16 more

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Nature Communications(2020)10.1038/s41467-020-18613-3

N/A

0DataRank · unranked

303 citations

Ki Hwan Kim, Hyo Jeong Lim, Amélie Boichard, Mina Nikanjam, Elizabeth Weihe +17 more

Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy

Cancers(2025)10.3390/cancers18010146

N/A

0DataRank · unranked

0 citations

Lap Ho, Tammy Pham, A Molinolo, Riley N. Jones, David R. Vera +4 more